Table 1.
Demographic and characteristics between the ESRD and Non-ESRD groups
| Characteristic | ESRD | Non-ESRD | p-valuea | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Total | 127,283 | 127,283 | |||
| Gender | 1 | ||||
| Male | 64,306 | 50.5 | 64,306 | 50.5 | |
| Female | 72,902 | 49.5 | 72,902 | 49.5 | |
| Age (yrs) | 1 | ||||
| < 65 | 68,698 | 54.0 | 68,698 | 54.0 | |
| ≥ 65 | 58,585 | 46.0 | 58,585 | 46.0 | |
| Urbanized level | 1 | ||||
| 1 (City) | 35,299 | 27.7 | 35,299 | 27.7 | |
| 2 | 57,162 | 44.9 | 57,162 | 44.9 | |
| 3 | 22,092 | 17.4 | 22,092 | 17.4 | |
| 4 (Village) | 12,730 | 10.0 | 12,730 | 10.0 | |
| Income (NTD, per month) | 1 | ||||
| 0 | 26,695 | 21.0 | 26,695 | 21.0 | |
| 1–15,840 | 20,261 | 15.9 | 20,261 | 15.9 | |
| 15,841–25,000 | 60,617 | 47.6 | 60,617 | 47.6 | |
| ≥ 25,001 | 19,710 | 15.5 | 19,710 | 15.5 | |
| DNI | 280 | 0.2 | 194 | 0.1 | <0.001 |
| Comorbidities | |||||
| DM | 71,155 | 55.9 | 71,155 | 55.9 | 1 |
| HTN | 117,545 | 92.4 | 117,545 | 92.4 | 1 |
| Autoimmune | 8345 | 6.6 | 7406 | 5.8 | <0.001 |
| Liver cirrhosis | 12,559 | 9.9 | 5588 | 4.4 | <0.001 |
| CAD | 69,109 | 54.3 | 48,835 | 38.4 | <0.001 |
| CVA | 49,042 | 38.5 | 38,602 | 30.3 | <0.001 |
| COPD | 30,454 | 23.9 | 30,704 | 24.1 | 0.246 |
Abbreviations: DNI deep neck infection, ESRD end-stage renal disease, NTD New Taiwan dollar, DM diabetes mellitus, HTN hypertension, CAD coronary artery disease, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease
aPearson’s chi-squared tests
Table 1 revealed the demographic and clinical characteristics between the ESRD and Non-ESRD groups. Gender, age, urbanized, income level, DM and HTN were balanced between the two groups. The incidence of DNI was significantly higher in the ESRD group (p < 0.001)